ElevateU

ElevateBio is a technology-driven cell and gene therapy company providing integrated R&D platforms, advanced manufacturing capabilities, and expertise to accelerate the development of transformative genetic medicines. The company operates both as an enabler for external partners—offering process innovation, cGMP manufacturing, viral vector production—and selectively develops its own portfolio. It has announced advancements such as proprietary lipid nanoparticle delivery with liver targeting potential. Key partnerships include Kyverna Therapeutics (cell therapies) and Novo Nordisk (gene editing for rare/cardiometabolic disease). Clinical results from internal programs are not publicly detailed.